The mechanism, stated fairly
Gut bacteria ferment fibre into short-chain fatty acids including butyrate. These fuel the cells lining your colon and act as signalling molecules — including stimulating GLP-1 release from intestinal L-cells.
People with obesity and metabolic disease tend to show different microbiome compositions from people without, including lower levels of certain species. That association is repeatedly observed.
What is much less clear is the direction of causation, and whether changing the microbiome with a capsule changes the outcome.
Akkermansia muciniphila specifically
Akkermansia has become the headline strain in this category, and unlike most probiotic marketing it has a human trial behind it.
A pilot randomised study published in Nature Medicine in 2019 gave pasteurised Akkermansia to overweight, insulin-resistant volunteers for three months. It found supplementation was safe and well tolerated, with improvements in insulin sensitivity and some metabolic markers versus placebo.
That is a genuine result. It is also roughly 32 participants over three months, explicitly framed as proof-of-concept, and not a weight loss trial.
What the CFU count tells you
For any probiotic, colony-forming units per serving is the central specification — it is how many live organisms you are actually getting.
A product that does not publish CFU per strain has omitted the most important number on the label. Ask for it. If the answer is not forthcoming, that is your answer.
Strain identity matters too: probiotic effects are strain-specific, so 'Lactobacillus' with no strain designation tells you very little.
Delivery is a real problem
Stomach acid kills most bacteria. Delayed-release capsules, enteric coatings and strain selection are genuine attempts to solve this, and a product addressing delivery has thought about the problem.
So has one that ships cold and tells you to refrigerate after opening. Live organisms degrade with heat and time, and a probiotic that sat in a warm warehouse may contain far fewer live organisms than the label claims.
Who should be careful
Probiotics are live organisms. For most healthy people they are low risk, but that is not universal.
Anyone immunocompromised, critically ill, or with a central venous catheter should not start a probiotic without medical advice — there are documented cases of infection in these groups.
An honest position
The microbiome is one of the more interesting areas in metabolic research and it is moving quickly. Some of what is sold now will probably turn out to matter.
But 'promising early research' and 'demonstrated to work' are different statements, and the gap between them is where most of this category's marketing lives.